Document is current
Any future updates will be listed below
-
Authors
Kawatani, Keiji https://orcid.org/0009-0004-9180-3219
Holm, Marie-Louise
Starling, Skylar C.
Martens, Yuka A.
Zhao, Jing https://orcid.org/0000-0002-4520-6307
Lu, Wenyan
Ren, Yingxue
Li, Zonghua
Jiang, Peizhou
Jiang, Yangying
Baker, Samantha K.
Wang, Ni
Roy, Bhaskar
Parsons, Tammee M.
Perkerson, Ralph B. III
Bao, Hanmei
Han, Xianlin
Bu, Guojun https://orcid.org/0000-0003-3491-1016
Kanekiyo, Takahisa https://orcid.org/0000-0001-6751-9374
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (RF1AG081203, U19AG069701, RF1AG071226, RF1AG068034, RF1AG057181, P30 AG013319, P30 AG044271)
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
Cure Alzheimer’s Fund
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
- License Information
-
More Information
Article History
Received: 24 June 2023
Revised: 5 December 2023
Accepted: 7 December 2023
First Online: 22 December 2023
Competing interests
: TK consults Ono Pharma, Inc. YAM is currently an employee of SciNeuro Pharmaceuticals. Other authors declare no competing interests.
